Sep07 ASCPT News: September 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Sep01 I am ASCPT: Deok Yong Yoon Deok Yong Yoon, PharmD, PhD, Postdoctoral Associate, University of Florida, Orlando, Florida Read More.. Sep01 I am ASCPT: Erica Woodahl Erica Woodahl, PhD, Professor, University of Montana, Missoula, Montana Read More.. Sep01 I am ASCPT: Akinyemi Oni-Orisan Akinyemi Oni-Orisan, PharmD, PhD, Assistant Professor, University of California San Francisco, San F... Read More.. Sep01 I am ASCPT: Reem Neal Reem Neal, MD, Postdoctoral Fellow, Mayo Clinic, Rochester, Minnesota Read More.. Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Sep01 I am ASCPT: Deok Yong Yoon Deok Yong Yoon, PharmD, PhD, Postdoctoral Associate, University of Florida, Orlando, Florida Read More.. Sep01 I am ASCPT: Erica Woodahl Erica Woodahl, PhD, Professor, University of Montana, Missoula, Montana Read More.. Sep01 I am ASCPT: Akinyemi Oni-Orisan Akinyemi Oni-Orisan, PharmD, PhD, Assistant Professor, University of California San Francisco, San F... Read More.. Sep01 I am ASCPT: Reem Neal Reem Neal, MD, Postdoctoral Fellow, Mayo Clinic, Rochester, Minnesota Read More.. Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Sep01 I am ASCPT: Erica Woodahl Erica Woodahl, PhD, Professor, University of Montana, Missoula, Montana Read More.. Sep01 I am ASCPT: Akinyemi Oni-Orisan Akinyemi Oni-Orisan, PharmD, PhD, Assistant Professor, University of California San Francisco, San F... Read More.. Sep01 I am ASCPT: Reem Neal Reem Neal, MD, Postdoctoral Fellow, Mayo Clinic, Rochester, Minnesota Read More.. Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Sep01 I am ASCPT: Akinyemi Oni-Orisan Akinyemi Oni-Orisan, PharmD, PhD, Assistant Professor, University of California San Francisco, San F... Read More.. Sep01 I am ASCPT: Reem Neal Reem Neal, MD, Postdoctoral Fellow, Mayo Clinic, Rochester, Minnesota Read More.. Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Sep01 I am ASCPT: Reem Neal Reem Neal, MD, Postdoctoral Fellow, Mayo Clinic, Rochester, Minnesota Read More.. Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Aug28 ASCPT Announces First Leadership Accelerator Cohort ASCPT is pleased to announce the participants of its newest program, the Leadership Accelerator. Read More.. Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Aug11 FDA News: Issue 17-1 August 2023 FDA Approves XACDURO (Sulbactam and Durlobactam) for the Treatment of Pneumonia Caused by Certain Di... Read More.. Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Aug04 FDA News: Issue 16-1 August 2023 FDA Approves COLUMVI (glofitamab-gxbm) for the Treatment of Adult Patients with Selected Relapsed or... Read More.. Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Aug03 ASCPT News: August 2023 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
Aug01 I am ASCPT: Kimberly Collins Kimberly Collins, PhD, Quantitative Medicine Scientist, Critical Path Institute, Indianapolis, IN Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 of 63
